MYC and medulloblastoma: While amplification of MYC defines Group 3 medulloblastomas and confers poor prognosis, such MYC amplification occurs in less than a quarter of Group 3 tumors, with a heterogenous set of other molecular mechanisms occurring in the remainder41,43.